Library
Welcome
to the library. Select a topic from the alphabetical listing below
just by clicking and you will be directed to reference citations
from published literature..
Notice:
This information found on Advantig.net is not intended to replace
professional medical advice or treatment. Our dietary supplements
are not intended to diagnose, treat, cure, or prevent any disease
or medical condition. Our self care products are designed for
your personal comfort and are not intended to replace professional
medical devices. Individual results may vary. Seek the advice
of a qualified professional for any lasting health concern and
share with your provider any information pertaining to your health
and well-being, including the use of supplemental nutrition.
Acidophilus
(Lactobacillus acidophilus)
Balli
F, Bertolani P, et al: High-dose bacteria-therapy for chronic
non-specific diarrhea of infancy. Pediatr Med Chir; 14 (1): 13-15,
1992.
Bonzalez
SN, Cardozo R, et al: Biotherapeutic role of fermented milk. Biotherapy;
8 (2): 129-34, 1994.
De
Simone C, Grassi PP, et al: Adherence of specific yogurt micro-organisms
to human peripheral blood lymphocytes. Microbios; 55 (222): 49-57,
1988.
Elmer
GW, Surawicz CM, et al: Biotherapeutic agents. A neglected modality
for the treatment and prevention of selected intestinal and vaginal
infections. JAMA; 275 (11): 870-76, 1996.
Gorback
SL: Lactic acid bacteria and human health. Ann Med; 22 (1): 37-41,
1990.
Gregori
G, de Andelis GL, et al: Use of oral bacteria therapy in childhood
during acute enteritis and functional chronic diarrhea. Clinical
experience. Acta Biomed Ateneo Parmense; 56 (1): 23-26, 1985.
Hilton
E, Isenberg HD, et al: Ingestion of yogurt containing Lactobacillus
acidophilus as prophylaxis for candidal vaginitis. Ann Intern
Med; 116 (5): 353-57, 1992.
Kailasapathy
K, Chin J: Survival and therapeutic potential of probiotic organisms
with reference to Lactobacillus acidophilus and Bifidobacterium
spp. Immunol Cell Biol; 78 (1): 80-88, 2000.
Michielutti
F, Bertini M, et al: Clinical assessment of a new oral bacterial
treatment for children with acute diarrhea. Minerva Med; 87 (11):
545-50, 1996.
Muller
G, Salzer H: [Long-term experience in the therapy and prevention
of unspecific vaginal discharge with a Lactobacillus vaccine].
Wien Klin Wochenschr; 95 (11): 371-74, 1983.
Reid
G, Bruce AW, et al: Is there a role for lactobacilli in prevention
of urogenital and intestinal infections? Clin Microbiol Rev; 3
(4): 335-44, 1990.
Reid
G, et al: Implantation of Lactobacillus casei var rhamnosus into
vagina. Lancet; 344: 1229, 1994.
Witsell DL, Garrett CG, et al: Effect of Lactobacillus acidophilus
on antibiotic-associated gastrointestinal morbidity: a prospective
randomized trial. J Otolaryngol; 24 (4): 230-33, 1995.
(top)
Aloe
(Aloe vera, Aloe barbadensis)
Blumenthal
M, et al, eds: The Complete German Commission E Monographs: Therapeutic
Guide to Herbal Medicines; 80-81, ©1998.
Fulton
JE Jr: The stimulation of postdermabrasion wound healing with
stabilized aloe vera gel-polyethylene oxide dressing. J Dermatol
Surg Oncol; 16 (5): 460-7, 1990.
Ghannam
N, et al: The antidiabetic activity of aloes: preliminary clinical
and experimental observations. Horm Res; 24 (4): 288-94, 1986.
Heggers
JP, et al: Experimental and clinical observations on frostbite.
Ann Emerg Med; 16 (9): 1056-62, 1987.
Schmidt
JM, Greenspoon JS: Aloe vera dermal wound gel is associated with
a delay in wound healing. Obstet Gynecol; 78 (1): 115-7, 1991.
Syed
TA, et al: Management of psoriasis with Aloe vera extract in a
hydrophilic cream: a placebo-controlled, double-blind study. Trop
Med Int Health; 1 (4): 505-9, 1996.
Visuthikosol
V, et al: Effect of aloe vera gel to healing of burn wound: a
clinical and histologic study. J Med Assoc Thai; 78 (8): 403-9,
1995.
(top)
Alpha
Lipoic Acid
Baur
A, Harrer T, et al: Alpha-lipoic acid is an effective inhibitor
of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr;
69 (15): 722-4, 1991.
Busse
E, Zimmer G, et al: Influence of alpha-lipoic acid on intracellular
glutathione in vitro and in vivo. Arzneimittelforschung; 42 (6):
829-31, 1992.
Han
D, et al: Alpha-lipoic acid increases intracellular glutathione
in a human T-lymphocyte Jurkat cell line. Biochem Biophys Res
Commun; 207 (1): 258-64, 1995.
Jacob
S, et al: Enhancement of glucose disposal in patients with type
2 diabetes by alpha-lipoic acid. Arzneimittelforschung; 45 (8):
872-4, 1995.
Jacob
S, et al: Oral administration of RAC-alpha-lipoic acid modulates
insulin sensitivity in patients with type-2 diabetes mellitus:
a placebo-controlled pilot trial. Free Radic Biol Med; 27 (3-4):
309-14, 1999.
Kagan
VE, et al: Recycling of vitamin E in human low density lipoprotein.
J Lipid Res; 33 (3): 385-97, 1992.
Kahler
K, et al: [Diabetes mellitus: a free radical-associated disease.
Results of adjuvant antioxidant supplementation. Z Gesmamte Inn
Med; 48 (5): 223-32, 1993.
Khanna
S, et al: Alpha-lipoic acid supplementation: tissue glutathione
homeostasis at rest and after exercise. J Appl Physiol; 86 (4):
1191-6, 1999.
Konrad
T, Vicini P, et al: Alpha-lipoic acid treatment decreases serum
lactate and pyruvate concentrations and improves glucose effectiveness
in lean and obese patients with type 2 diabetes. Diabetes Care;
22 (2): 280-7, 1999.
Kunt
T, Forst T, et al: Alpha-lipoic acid reduces expression of vascular
cell adhesion molecule-1 and endothelial adhesion of human monocytes
after stimulation with advanced glycation end products. Clin Sci;
96 (1): 75-82, 1999.
Marangon
K, et al: Comparison of the effect of alpha-lipoic acid and alpha-tocopherol
supplementation on measures of oxidative stress. Free Radic Biol
Med; 27 (9-10): 1114-21, 1999.
Merin
JP, et al: Alpha-lipoic acid blocks HIV-1 LTR-dependent expression
of hygromycin resistance in THP-1 stable transformants. FEBS Lett;
394 (1): 9-13, 1996.
Monograph:
Alpha lipoic acid. Altern Med Rev; 3 (4): 308-11, 1998.
Murray MT: Encylopedia of Nutritional Supplements: the essential
guide for improving your health naturally; 343-46, ©1996.
Reljanovic
M, Reichel G, et al: Treatment of diabetic polyneuropathy with
the antioxidant thioctic acid (alpha-lipoic acid): a two-year
multicenter randomized double-blind placebo-controlled trial (ALADIN
II). Alpha lipoic acid in diabetic neuropathy. Free Radic Res;
31 (3): 171-9, 1999.
Shoji
S, et al: Thiamine disulfide as a potent inhibitor of human immunodeficiency
virus (type-1) production. Biochem Biophys Res Commun; 205 (1):
967-75, 1994.
Strokov
IA, et al: [The efficacy of the intravenous administration of
the trometamol salt of thioctic (alpha-lipoic) acid in diabetic
neuropathy. Zh Nevrol Psikhiatr Im S S Korsakova; 99 (6): 18-22,
1999.
Suzuki
YJ, Aggerwal BB, Packer L: Alpha-lipoic acid is a potent inhibitor
of NF-kappa B activation in human T cells. Biochem Biophys Res
Commun; 189 (3): 1709-15, 1992.
Ziegler
D, et al: Effects of treatment with the antioxidant alpha-lipoic
acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month
randomized controlled multicenter trial (DEKAN Study). Deutsche
Kardiale Autonome Neuropathie. Diabetes Care; 20 (3): 369-73,
1997.
Ziegler
D, et al: Treatment of symptomatic diabetic peripheral neuropathy
with the antioxidant alpha-lipoic acid. A 3-week multicentre randomized
controlled trial (ALADIN Study). Diabetologia; 38 (12): 1425-33,
1995.
Ziegler
D, Gries FA: Alpha-lipoic acid in the treatment of diabetic peripheral
and cardiac autonomic neuropathy. Diabetes; 46 (suppl 2): S62-6,
1997.
(top)
Arthritis
Dingle
JT: The effects of NSAID on the matrix of human articular cartilages.
Z Rheumatology; 58 (3): 125-9, 1999.
Kjeldsen-Kragh
J: Rheumatoid arthritis treated with vegetarian diets. American
J Clin Nutrition; 70 (3 suppl): 594s-600s, 1999.
Kremer
JM, Bigaoutte J: Nutrient intake of patients with rheumatoid arthritis
is deficient in pyridoxine, zinc, copper, and magnesium. J Rheumatology;
23 (6): 990-4, 1996.
Kremer
JM, Jubiz W, et al: Fish-oil fatty acid supplementation in active
rheumatoid arthritis. A double-blinded, controlled, crossover
study. Ann Internal Medicine; 106 (4): 497-503, 1987.
Lopes
Vaz A: Double-blind clinical evaluation of the relative efficacy
of ibuprofen and glucosamine sulfate in the management of osteoarthritis
of the knee in out-patients. Curr Med Res Opin; 8 (3): 145-9,
1982.
Nenonen
MT, Helve TA, Rauma AL, Hanninen OO: Uncooked, lactobacilli-rich,
vegan food and rheumatoid arthritis. British J Rheumatology; 37
(3): 274-81, 1998.
Qui
GX, Gao SN, Giacovelli G, Rovati L, Setnikar I: Efficacy and safety
of glucosamine sulfate versus ibuprofen in patients with knee
osteoarthritis. Arzneimittelforschung; 49 (5): 469-74, 1998.
Shapiro
JA, Koepsell TD, Voight LF, Dugowson CE, Kestin M, Nelson JL:
Diet and rheumatoid arthritis in women: a possible protective
effect of fish consumption. Epidemiology; 7 (3): 256-63, 1996.
(top)
Astragalus (Astragalus
membranaceus)
Chen
LX, Liao JZ, Guo WQ: [Effects of Astragalus membranaceus on left
ventricular function and oxygen free radical in acute myocardial
infarction patients and mechanism of its cardiotonic action].
Chung Kuo Chung Hsi I Chieh Ho Tsa Chih; 15 (3): 141-3, 1995.
Chu
DT, et al: [The in vitro potentiation of LAK cell cytotoxicity
in cancer and AIDS patients induced by F3--a fractionated extract
of Astragalus membranaceus]. Chung Hua Chung Liu Tsa Chih; 16
(3): 167-71, 1994.
Chu
DT, et al: Fractionated extract of Astragalus membranaceus, a
Chinese medicinal herb, potentiates LAK cell cytotoxicity generated
by a low dose of recombinant interleukin-2. J Clin Lab Immunol;
26 (4): 183-7, l988.
Chu
DT, et al: Immunotherapy with Chinese medicinal herbs. II. Reversal
of cyclophosphamide-induced immune suppression by adiministration
of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol;
25 (3): 125-9, 1988.
Hsu
HY, et al: Oriental Materia Medica. A Concise Guide; 521-23, ©1986.
Jin
C, Dai RH: [Effect of Astragalus membranaceus on erythrocyte sodium
content and sodium transport in the coronary heart disease]. Chung
Hsi I Chieh Ho Tsa Chih; 11 (11): 651-3, 1991.
Li
SQ, Yuan RX, Gao H: [Clinical obserbvations on the treatment of
ischemic heart disease with Astragalus membranaceus]. Chung Kuo
Hsi I Chieh Ho Tsa Chih; 15 (2): 77-80, 1995.
Luo
HM, Dai RH, Li Y: [Nuclear cardiology study on effective ingredients
of Astragalus membranaceus in treating heart failure]. Chung Kuo
Chung Hsi I Chieh Ho Tsa Chih; 15 (12): 707-9, 1995.
Sun
Y, et al: Immune restoration and/or augmentation of local graft
versus host reaction by traditional Chinese medicinal herbs. Cancer;
52 (1): 70-3, 1983.
Sun
Y, et al: Preliminary observations on the effects of the Chinese
medicinal herbs Astragalus membranaceus and Ligistrum lucidum
on lymphocyte blastogenic responses. J Biol Response Mod; 2 (3):
227-37, 1983.
Wang
DC: [Influence of Astragalus membranaceus (AM) polysaccharide
FB on immunologic function of human periphery blood lymphocyte].
Chung Hua Chung Liu Tsa Chih; 11 (3): 180-3, 1989.
Zhao
KW, Kong HY: [Effect of Astragalan on secretion of tumor necrosis
factors in human peripheral blood mononuclear cells]. Chung Kuo
Chung Hsi I Ho Tsa Chih; 13 (5): 263-5, 1993.
(top)
Beta-Carotene
Abril
ER, et al: Beta-carotene stimulates human leukocytes to secrete
a novel cytokine. J Leukoc Biol; 45 (3): 255-61, 1989.
Beno
I, et al: [Precancerous conditions and carcinomas of the stomach
and colorectum: blood levels of selected micronutrients]. Bratisl
Lek Listy; 98 (12): 674-7, 1997.
Choi
MA, Kim BS, Yu R: Serum antioxidative vitamin levels and lipid
peroxidation in gastric carcinoma patients. Cancer Lett; 136 (1):
89-93, 1999.
Cook NR, et al: Beta-carotene supplementation for patients with
low baseline levels and decreased risks of total and prostate
carcinoma. Cancer; 86 (9): 1783-92, 1999.
Fusaro
RM, Johnson JA: Hereditary polymorphic light eruption in American
Indians. Photoprotection and prevention of streptococcal pyoderma
and glomerulonephritis. JAMA; 244 (13): 1456-9, 1980.
Garewal
HS, et al: A preliminary trial of beta-carotene in subjects infected
with the human immunodeficiency virus. J Nutr; 122 (3 suppl):
728-32, 1992.
Greenberg
ER, et al: A clinical trial of beta carotene to prevent basal-cell
and squamous-cell cancers of the skin. The Skin Cancer Prevention
Group. N Engl J Med; 232 (12): 789-95, 1990.
Hughes
DA, et al: The effect of beta carotene supplementation on the
immune function of blood monocytes from healthy male nonsmokers.
J Lab Clin Med; 129 (3): 309-17, 1997.
Kaaks
R, et al: Nutrient intake patterns and gastric cancer risk: a
case-control study in Belgium. Int J Cancer; 78 (4): 415-20, 1998.
Kazi
N, et al: Immunomodulatory effect of beta-carotene on T lymphocyte
subsets in patients with resected colonic polyps and cancer. Nutr
Cancer; 28 (2): 140-5, 1997.
Kune
GA, et al: Diet, alcohol, smoking, serum beta-carotene and vitamin
A in male nonmelanocytic skin cancer patients and controls. Nutr
Cancer; 18 (3): 237-44, 1992.
Mathews-Roth
MM, et al: Beta carotene therapy for erythropoietic protoporphyria
and other photosensitivity diseases. Arch Dermatol; 113 (9): 1229-32,
1977.
Mathews-Roth
MM: Carotenoids in erythreopoietic protoporphyria and other photosensitivity
diseases. Ann NY Acad Sci; 691: 127-38, 1993.
Mathews-Roth
MM: Photoprotection by carotenoids. Fed Proc; 46 (5): 1890-3,
1987.
Omenn
GS, et al: Effects of a combination of beta carotene and vitamin
A on lung cancer and cardiovascular disease. N Engl J Med; 334
(18): 1150-5, 1996.
Omenn
GS, et al: Risk factors for lung cancer and for intervention effects
in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl
Cancer Inst; 88 (21): 1550-9, 1996.
Patrick
L: Nutrients and HIV: part one--beta carotene and selenium. Altern
Med Rev; 4 (6): 403-13, 1999.
Stahelin
HB, et al: Beta-carotene and cancer prevention: the Basel study.
Am J Clin Nutr; 53 (1 suppl): 265s-269s, 1991.
The
effect of vitamin E and beta carotene on the incidence of lung
cancer and other cancers in male smokers. The Alpha-Tocopherol,
Beta Carotene Cancer Prevention Study Group. N Engl J Med; 330
(15): 1029-35, 1994.
Wiskemann
A: [Light protection and increase of UV tolerance]. Z Hautkr;
59 (21): 1454-62, 1984.
Ysubono
Y, et al: Plasma antioxidant vitamins and carotenoids in five
Japanese populations with varied mortality from gastric cancer.
Nutr Cancer; 34 (1): 56-61, 1999.
(top)
Bilberry
(Vaccinium myrtillus)
Boniface
R, Robert A M: Influence of anthocyanisides on human connective
tissue metabolism. Klinische Monatsblatter fur Augenheilkunde;
209 (6): 368-372, 1996.
Laplaud
PM, Lelurbre A, Chapman MJ: Antioxidant action of Vaccinium myrtillus
extract on human low density lipoproteins in vitro: meidal observations.
Fundam Clin Pharmacol; 11(1): 35-40, 1997.
Murray
M: The Healing Power of Herbs: The Enlightened Person's Guide
to the Wonders of Medicinal Plants. Rev and expanded 2nd ed. 50-57.
Scharrer
A, Ober M: Anthocyanisides in the treatment of retinopathies.
Klinische Monatsblatter fur Augenheilkunde; 178 (5): 386-389,
1981.
(top)
Biotin
(Coenzyme R, Vitamin H)
Erlichman
M, Goldstein R, et al: Infantile flexural seborrhoeic dermatitis.
Neither biotin nor essential fatty acid deficiency. Arch Dis Child;
56 (7): 560-62, 1981.
Floersheim
GL: Treatment of brittle fingernails with biotin. Z Hautkr; 64
(1): 41-48, 1989.
Furukawa
Y: [Enhancement of glucose-induced insulin secretion and modification
of glucose metabolism by biotin]. Nippon Rinsho; 57 (10): 2261-69,
1999.
Hochman
LG, Scher RK, et al: Brittle nails: response to daily biotin supplementation.
Cutis; 51 (4): 303-05, 1993.
Keipert
JA: Oral use of biotin in seborrhoeic dermatitis of infancy: a
controlled trial. Med J Aust; 1 (16): 584-85, 1976.
Koutsikos
D, Fourtounas C, et al: Oral glucose tolerance test after high-dose
i.v. biotin administration in normoglucemic hemodialysis patients.
Ren Fail; 18 (1): 131-37, 1996.
Messaritakis
J, Kattamis C, et al: Generalized seborrhoeic dermatitis. Clinical
and therapeutic data of 25 patients. Arch Dis Child; 50 (11):
871-74, 1975.
(top)
Boron
Helliwell
TR, et al: Elemental analysis of femoral bone from patients with
fractured neck of femur or osteoarthrosis. Bone; 18 (2): 151-7,
1996.
McCoy
H, et al: Relation of boron to the composition and mechanical
properties of bone. Environ Health Perspect; 102 (Suppl 7): 49-53,
1994.
Naghii
MR, Samman S: The role of boron in nutrition and metabolism. Prog
Food Nutr Sci; 17 (4): 331-49, 1993.
Naghii
MR: The significance of dietary boron, with particular reference
to athletes. Nutr Health; 13 (1): 31-7, 1999.
Newnham
RE: Agricultural practices affect arthritis. Nutr Health; 7 (2):
89-100, 1991.
Newnham
RE: Essentiality of boron for healthy bones and joints. Environ
Health Perspect; 102 (Suppl 7): 83-5, 1994.
Nielsen
FH, et al: Effect of dietary boron on mineral, estrogen, and testosterone
metabolism in postmenopausal women. FASEB J; 1 (5): 394-7, 1987.
Nielsen
FH: New essential trace elements for the life sciences. Biol Trace
Elem Res; 26-27: 599-611, 1990.
Nielsen
FH: Studies on the relationship between boron and magnesium which
possibly affects the formation and maintenance of bones. Magnes
Trace Elem; 9 (2): 61-9, 1990.
Nielsen
FH: The justification for providing dietary guidance for the nutritional
intake of boron. Biol Trace Elem Res; 66 (1-3): 319-30, 1998.
Penland
JG: Dietary boron, brain function, and cognitive performance.
Environ Health Perspect; 102 (Suppl 7): 65-72, 1994.
Penland
JG: The importance of boron nutrition for brain and psychological
function. Biol Trace Elem Res; 66 (1-3): 299-317, 1998.
Rainey CJ, et al: J Am Diet Assoc; 99 (3): 335-40, 1999.
(top)
Boswellia
(Boswellia serrata)
Ammon HP, et al: Inhibition of leukotriene B4 formation in rat
peritoneal neutrophils by an ethanolic extract of the gum resin
exudate of Bosewellia serrata. Planta Med; 57 (3): 203-7, 1991.
Ammon HP, et al: Mechanism of antiinflammatory actions of curcumine
and boswellic acids. J Ethnopharmacol; 38 (2-3): 113-9, 1993.
Foster S: Better Nutrition's 1999 Herb Guide. Better Nutrition;
61 (4): 70-77, 1999.
Gupta I, et al: Effects of Boswellia serrata gum resin in patients
with bronchial asthma: results of a double-blind, placebo-controlled,
6-week clinical study. Eur J Med Res; 13 (11): 511-4, 1998.
Gupta I, et al: Effects of Boswellia serrata gum resin in patients
with ulcerative colitis. Eur J Med Res; 2 (1): 37-43, 1997.
Monograph: Boswellia serrata. Altern Med Rev; 3 (4): 306-7, 1998.
Safayhi H, et al: Concentration-dependent potentiating and inhibitory
effects of Boswellia extracts on 5-lipoxygenase product formation
in stimulated PMNL. Planta Med; 66 (2): 110-3, 2000.
Sander O, et al: [Is H15 (resin extract of Boswellia serrata,
"incense") a useful supplement to established drug therapy
of chronic polyarthritis? Results of a double-blind pilot study].
Z Rheumatol; 57 (1): 11-16, 1998.
Singh GB, Atal CK: Pharmacology of an extract of salai guggal
ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent.
Agents Actions; 18 (3-4): 407-12, 1986.
Zucker M: Boswellia: an ancient herb combats arthritis. Natural
Way for Better Health; p.60-61, 7/31/1995.
(top)
Brewer's
Yeast (Saccharomyces cerevisiae)
Anderson
RA, et al: Elevated intakes of supplemental chromium improve glucose
and insulin variables in individuals with type 2 diabetes. Diabetes;
46 (11): 1786-91, 1997.
Anderson
RA: Chromium, glucose tolerance and diabetes. J Am Coll Nutr;
17 (6): 548-55, 1998.
Blumenthal
M, et al (eds.): The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicines. 1st ed: 234, ©1998
American Botanical Council.
De
Abreu J, Millan N: Effect of addition of brewer's yeast to soy
protein and casein on plasma cholesterol levels of rabbits. Arch
Latinoam Nutr; 44 (1): 18-22, 1994.
Offenbacher
EG, Pi-Sunyer FX: Beneficial effect of chromium-rich yeast on
glucose tolerance and blood lipids in elderly subjects. Diabetes,;
29 (11): 919-25, 1980.
Weber
G, et al: [Treatment of acne with a yeast preparation]. Fortschr
Med; 107 (26): 563-6, 1989.
(top)
Bromelain
Blumenthal
M, et al (eds.): The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicines. 1st ed: 94-5, American
Botanical Council, ©1998.
Bromelain
and musculoskeletal injuries. J Amer Holistic Veterinary Med Assoc;
16 (3): 29, 1997.
Cichoke
AJ: Fighting sports injuries with enzymes. Nutrition Sci News;
1 (5): 42,44, 1996.
Eckert
K, et al: Effects of oral bromelain administration on the impaired
immunocytotoxicity of mononuclear cells from mammary tumor patients.
Oncol Rep; 6 (6): 1191-9, 1999.
Felton
GE: Fibrinolytic and antithrombotic action of bromelain may eliminate
thrombosis in heart patients. Med Hypotheses; 6 (11): 1123-33,
1980.
Kelly
GS: Bromelain: a literature review and discussion of its therapeutic
applications. Alt Med Rev; 1 (4): 243-57, 1996.
Klein
G, Kullich W: [Reducing pain by oral enzyme therapy in rheumatic
diseases]. Wien Med Wochenschr; 149 (21-22): 577-80, 1999.
Masson
M: [Bromelain in blunt injuries of the locomotor system. A study
of observed applications in general practice]. Fortschr Med; 113
(19): 303-6, 1995.
Metzig
C, et al: Bromelain proteases reduce human platelet aggregation
in vitro, adhesion to bovine endothelial cells and thrombus formation
in rat vessels in vivo. In Vivo; 13 (1): 7-12, 1999.
Taussig
SJ, Batkin S: Bromelain, the enzyme complex of pineapple (Ananas
comosus) and its clinical application. An update. J Ethnopharmacol;
22: 191-203, 1988.
(top)
Calcium
Bendich A, Leader S, Muhuri P: Supplemental calcium for the prevention
of hip fracture: potential health-economic benefits. Clin Ther;
21 (6): 1058-72, 1999.
Bostick
RM, Fosdick L, et al: Calcium and colorectal epithelial cell proliferation
in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled
clinical trial. J Natl Cancer Inst; 87 (17): 1307-15, 1995.
Guidelines
boost calcium requirements. Harvard Health Letter; 22 (12): 7,
1997.
Holt
PR, Atillasoy EO, et al: Modulation of abnormal colonic epithelial
cell proliferation and differentiation by low-fat dairy foods:
a randomized controlled trial. JAMA; 280 (12): 1074-9, 1998.
Holt
PR: Dairy foods and prevention of colon cancer: human studies.
J Am Coll Nutr; 18 (5 suppl): 379s-391s, 1999.
Martinez
ME, Willet WC: Calcium, vitamin D, and colorectal cancer: a review
of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev;
7 (2): 163-8, 1998.
McCarron
DA: Role of adequate dietary calcium intake in the prevention
and management of salt-sensitive hypertension. Am J Clin Nutr
65 (2 suppl): 712s-716s, 1997.
Meunier
P: Prevention of hip fractures by correcting calcium and vitamin
D insufficiencies in elderly people. Scand J Rheumatol Suppl;
103: 75-78, 1996.
Murray
Michael T: Enyclopedia of nutritional supplements: the essential
guide for improving your health naturally. 149-158.
National
Institute of Arthritis and Musculoskeletal and Skin Diseases:
Osteoporosis: progress and promise.
Optimal
calcium intake. NIH Consenus Statement Online; 12 (4): 1-31, 1994.
Prichard
RS, Baron JA, Gerhardsson de Verdier M: Dietary calcium, vitamin
D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer
Epidemiol Biomarkers Prev; 5 (11): 897-900, 1996.
(top)
Cat's
Claw (Uncaria tomentosa)
Aquino,
R., et al: Plant metabolites. New compounds and anti-inflammatory
activity of Uncaria tomentosa. Journal of Natural Products; 54
(2): 453-59, 1991.
Cerri,
R. et al: New Quinovic Acid Glycosides from Uncaria tomentosa.
Journal of Natural Products; 51: 257-61, 1988.
Reinhard,
K.-H.: Uncaria tomentosa (Willd.) D.C.: cat's claw, una de gato,
or saventaro. J Altern Complement Med; 5 (2): 143-51, 1999.
Santa
Maria A, et al: Evaluation of the toxicity of Uncaria tomentosa
by bioassays in vitro. J Ethnopharmacol; 57 (3): 183-87, 1997.
Senatore,
A, et al: Phytochemical and biological study of Uncaria tomentosa.
Boll Soc Ital Biol Sper; 65 (6): 517-20. 1989.
Sheng
Y, et al: Enhanced DNA repair, immune function and reduced toxicity
of C-MED-100, a novel aqueous extract from Uncaria tomentosa.
J Ethnopharmacol; 69 (2): 115-26, 2000.
Wagner,
H, et al: Planta Medica; 51: 419-23, 1985.
(top)
Citrus Bioflavonoids
Ameer
B, Weintraub RA: Drug interactions with grapefruit juice. Clin
Pharmacokinet; 33 (2): 103-21, 1997.
Bear
WL, Teel RW: Effects of citrus flavonoids on the mutagenicity
of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer
Res; 20 (5B): 3609-14, 2000.
Berkarda
B, et al: Inhibitory effect of hesperidin on tumour initiation
and promotion in mouse skin. Res Exp Med (Berl); 198 (2): 93-9,
1998.
Bok
SH, et al: Plasma and hepatic cholesterol and hepatic activities
of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol
transferase are lower in rats fed citrus peel extract or a mixture
of citrus bioflavonoids. J Nutr; 129 (6): 1182-5, 1999.
Chen
YT, et al: Flavonoids as superoxide scavengers and antioxidants.
Free Radic Biol Med; 9 (1): 19-21, 1990.
Galati
EM, et al: Biological effects of hesperidin, a citrus flavonoid.
(Note I): antiinflammatory and analgesic activity. Farmaco; 40
(11): 709-12, 1994.
Ginberg
LN, et al: Protective effects of rutin against hemoglobin oxidation.
Biochem Pharmacol; 48 (4): 643-9, 1994.
Koyuncu
H, et al: Preventive effect of hesperidin against inflammation
in CD-1 mouse skin caused by tumor promoter. Anticancer Res; 19
(4B): 3237-41, 1999.
La
Casa C, et al: Evidence for protective and antioxidant properties
of rutin, a natural flavone, against ethanol induced gastric lesions.
J Ethnopharmacol; 71 (1-2): 45-53, 2000.
Lee
YS, et al: Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid
dehydrogenase. Clin Pharmacol Ther; 59 (1): 62-71, 1996.
Martin
MJ, et al: Antiulcer effect of naringin on gastric lesions induced
by ethanol in rats. Pharmacology; 49 (3): 144-50, 1994.
Miyake
Y, et al: Protective effects of lemon bioflavonoids on oxidative
stress in diabetic rats. Lipids; 33 (7): 689-95, 1998.
Murray
MT: Encyclopedia of Nutritional Supplements; p. 330, 1996.
Negre-Salvayre
A, et al: Additional antilipoperoxidant activities of alpha-tocopherol
and ascorbic acid on membrane-like systems are potentiated by
rutin. Pharmacology; 42 (5): 262-72, 1991.
Ortolani
O, et al: Protective effects of N-acetylcysteine and rutin on
the lipid peroxidation of the lung epithelium during the adult
respiratory distress syndrome. Shock; 13 (1): 14-8, 2000.
Parmar
NS: The gastric anti-ulcer activity of naringenin, a specific
histidine decarboxylase inhibitor. Int J Tissue React; 5 (4):
415-20, 1983.
Russo
A, et al; Bioflavonoids as antiradicals, antioxidants ans DNA
cleavage protectors. Cell Biol Toxicol; 16 (2): 91-8, 2000.
Shin
YW, et al: Hypocholesterolemic effect of naringin associated with
hepatic cholesterol regulating enzyme changes in rats. Int J Vitam
Nutr Res; 69 (5): 341-7, 1999.
So
FV, et al: Inhibition of human breast cancer cell proliferation
and delay of mammary tumorigenesis by flavonoids and citrus juices.
Nutr Cancer; 26 (2): 167-81, 1996.
Wacker
A, Eilmes HG: [Antiviral activity of plant components. 1st communication:
Flavonoids]. Arzneimittelforschung; 28 (3): 347-50, 1978.
Webster
RP, et al: Protective effect of rutin, a flavonol glycoside, on
the carcinogen-induced DNA damage and repair enzymes in rats.
Cancer Lett; 109 (1-2): 185-91, 1996.
(top)
Copper
Bialkowska
M, et al: Hair zinc and copper concentration in survivors of myocardial
infarction. Ann Nutr Metab; 31 (5): 327-32, 1987.
Davydenko NV, et al: [The relationship between the copper and
zinc intake with food and the prevalence of ischemic heart disease
and its risk factors]. Lik Sprava; 5-6: 73-7, 1995.
Famaey
JP: Free radicals and activated oxygen. Eur J Rheumatol Inflamm;
5 (4): 350-9, 1982.
Gyorffry
EJ, Chan H: Copper deficiency and microcytic anemia resulting
from prolonged ingestion of over-the-counter zinc. Am J Gastroenterol;
87 (8): 1054-5, 1992.
Hoffman
HN II, et al: Zinc-induced copper deficiency. Gastroenterology;
94 (2): 508-12, 1988.
Klevay
LM: Cardiovascular disease from copper deficiency--a history.
J Nutr; 130 (2s Suppl): 489s-492s, 2000.
Klevay
LM: Lack of a recommended dietary allowance for copper may be
hazardous to your health. J Am Coll Nutr; 17 (4): 322-6, 1998.
Kremer
JM, Bigaouette J: Nutrient intake of patients with rheumatoid
arthritis is deficient in pyridoxine, zinc, copper, and magnesium.
J Rheumatol; 23 (6): 990-4, 1996.
Lindvall
S, Rydell G: Influence of various compounds on the degradation
of hyaluronic acid by a myeloperoxidase system. Chem Biol Interact;
90 (1): 1-12, 1994.
Miche
H, et al: Copper (II) interactions with nonsteroidal antiinflammatory
agents. II. Anthranilic acid as a potential OH-inactivating ligand.
J Inorg Biochem; 68 (1): 27-38, 1997.
Miesel
R, Zuber M: Copper-dependent antioxidase defenses in inflammatory
and autoimmune rheumatic diseases. Inflammation; 17 (3): 283-94,
1993.
Milanino
R, et al: Copper and inflammation--a possible rationale for the
pharmacological manipulation of inflammatory disorders. Agents
Actions; 16 (6): 504-13, 1985.
Reunanen
A, et al: Serum calcium, magnesium, and zinc and risk of cardiovascular
death. Eur J Clin Nutr; 50 (7): 431-7, 1996.
Russo
C, et al: Antioxidant status and lipid peroxidation in patients
with essential hypertension. J Hypertens; 16 (9): 1267-71, 1998.
Saari
JT, Schuschke DA: Cardiovascular effects of dietary copper deficiency.
Biofactors; 10 (4): 359-75, 1999.
Saltman
PD, Strause LG: The role of trace minerals in osteoporosis. J
Am Coll Nutr; 12 (4): 384-9, 1993.
Schmidt
H, et al: [The skeletal changes in premature infants with a copper
deficiency]. Rof Fortschr Geb Rontgensrt Neuen Bildgeb Verfahr;
155 (1): 38-42, 1991.
Simon
SR, et al: Copper deficiency and sideroblastic anemia associated
with zinc ingestion. Am J Hematol; 28 (3): 181-3, 1988.
Williams
DM: Copper deficiency in humans. Semin Hematol; 20 (2): 118-28,
1983.
(top)
CoQ10
(Coenzyme Q-10)
Lieberman
S, Bruning N: The Real Vitamin and Mineral Book
Mortensen
SA, Vadhanaviit S, Muratsu K, Folkers k: Coenzme Q10: clinical
benefits with biochemical correlates suggesting a scientific breakthrough
in the management of chronic heart failure. Int J. Tissue React,
12(3): 155-162, 1990.
Murray
M: Encyclopedia of Nutritional Supplements: the essential guide
for improving your health naturally.
Neuzil
J, Witting PK, Stocker R: Alpha tocopheryl hydroquinone is an
efficient multifunctional inhibitor of radical-initiated oxidation
of low density lipoprotein lipids. Proc. Natl. Acad. Sci. USA,
94(15): 7885-90, 1997.
Soja
AM, Mortensen SA: Treatment of chronic cardiac insufficiency with
coenzyme Q10, results of meta-analysis in controlled clinical
trials. Ugeskr Laeger, 159(49): 7302-8, 1997.
Soja
AM, Mortensen SA: Treatment of congestive heart failure with coenzyme
Q10 illuminated by meta-analyses of clinical trials. Mol Aspects
Med, 18: S159-68, 1997.
(top)
Cranberry (Vaccinium
macrocarpon)
Avorn
J, et al: Reduction of bacteriuria and pyuria after ingestion
of cranberry juice. JAMA; 271 (10): 751-4, 1994.
Fleet
JC: New support for a folk remedy: cranberry juice reduces bacteriuria
and pyuria in elderly women. Nutr Rev; 52 (5): 168-70, 1994.
Foxman
B, et al: First-time urinary tract infection and sexual behavior.
Epidemiology; 6 (12): 162-8, 1995.
Kinney
AB, Blount M: Effect of cranberry juice on urinary pH. Nurs Res;
28 (5): 287-90, 1979.
Schmidt
DR, Sobota AE: An examination of the anti-adherence activity of
cranberry juice on urinary and nonurinary bacterial isolates.
Microbios; 55 (224-225): 173-81, 1988.
Simpson
GM, Khajawall AM: Urinary acidifiers in phencyclidine detoxification.
Hillside J Clin Psychiatry; 5 (2): 161-8, 1983.
Sobota
AE: Inhibition of bacterial adherence by cranberry juice: potential
use for the treatment of urinary tract infections. J Urol; 131
(5): 1013-6, 1984.
(top)
Creatine
(Creatine monohydrate)
Barnett
C, et al: Effects of oral creatine supplementation on multiple
sprint cycle performance. Aust J Sci Med Sport; 28 (1): 35-9,
1996.
Becque
MD, et al: Effects of oral creatine supplementation on muscular
strength and body composition. Med Sci Sports Exerc; 32 (3): 654-8,
2000.
Bosco C, et al: Effect of oral creatine supplementation on jumping
and running performance. Int J Sports Med; 18 (5): 369-72, 1997.
Burke
LM, et al: Effect of oral creatine supplementation on single-effort
sprint performance in elite swimmers. Int J Sport Nutr; 6 (3):
222-33, 1996.
Casey
A, et al: Creatine ingestion favorably affects performance and
muscle metabolism during maximal exercise in humans. Am J Physiol;
271 (1 Pt 1): E31-7, 1996.
Febbraio
MA, et al: Effect of creatine supplementation on intramuscular
TCr, metabolism and performance during intermittent, supramaximal
exercise in humans. Acta Physiol Scand; 155 (4): 387-95, 1995.
Grindstaff
PD, et al: Effects of creatine supplementation on repetitive sprint
performance and body composition in competitive swimmers. Int
J Sport Nutr; 7 (4): 330-46, 1997.
Jacobs
I, et al: Creatine ingestion increases anaerobic capacity and
maximum accumulated oxygen deficit. Can J Appl Physiol; 22 (3):
231-43, 1997.
Javierre
C, et al: Creatine supplementation does not improve physical performance
in a 150 m race. Rev Esp Fisiol; 53 (4): 343-8, 1997.
Jones
AM, et al: Oral creatine supplementation improves multiple sprint
performance in elite ice-hockey players. J Sports Med Phys Fitness;
39 (3): 189-96, 1999.
Kreider
RB, et al: Effects of creatine supplementation on body composition,
strength, and sprint performance. Med Sci Sports Exerc; 30 (1):
73-82, 1998.
McNaughton
LR, et al: The effects of creatine supplementation on high-intensity
exercise performance in elite performers. Eur J Appl Physiol Occup
Physiol; 78 (3): 236-40, 1998.
Mihic
S, et al: Acute creatine loading increases fat-free mass, but
does not affect blood pressure, plasma creatinine, or CK activity
in men and women. Med Sci Sports Exerc; 32 (2): 291-6, 2000.
Mujika
I, et al: Creatine supplementation does not improve sprint performance
in competitive swimmers. Med Sci Sports Exerc; 28 (11): 1435-41,
1996.
Odland LM, et al: Effect of oral creatine supplementation on muscle
[PCr] and short-term maximum power output. Med Sci Sports Exerc;
29 (2): 216-9, 1997.
Prevost
MC, et al: Creatine supplementation enhances intermittent work
performance. Res Q Exerc Sport; 68 (3): 233-40, 1997.
Redondo
DR, et al: The effect of oral creatine monohydrate supplementation
on running velocity. Int J Sport Nutr; 6 (3): 213-21, 1996.
Rico-Sanz
J, Mendo Marco MT: Creatine enhances oxygen uptake and performance
during alternating intensity exercise. Med Sci Sports Exerc; 32
(2): 379-85, 2000.
Rossiter
HB, et al: The effect of oral creatine supplementation on the
1000-m performance of competitive rowers. J Sports Sci; 14 (2):
175-9, 1996.
Smith
JC, et al: Effect of oral creatine ingestion on parameters of
the work rate-time relationship and time to exhaustion in high-intensity
cycling. Eur J Appl Physiol Occup Physiol; 77 (4): 360-5, 1998.
Stone
MH, et al: Effects of in-season (5 weeks) creatine pyruvate supplementation
on anaerobic performance and body composition in American football
players. Int J Sport Nutr; 9 (2): 146-65, 1999.
Stout
J, et al: Effect of creatine loading on neuromuscular fatigue
threshold. J Appl Physiol; 88 (1): 109-12, 2000.
Terrillion
KA, et al: The effect of creatine supplementation on two 700-m
maximal running bouts. Int J Sport Nutr; 7 (2): 138-43, 1997.
Urbanski
RL, et al: Creatine supplementation differentially affects maximal
isometric strength and time to fatigue in large and small muscle
groups. Int J Sport Nutr; 9 (2): 136-45, 1999.
Vandebuerie
F, et al: Effect of creatine loading on endurance capacity and
sprint power in cyclists. Int J Sports Med; 19 (7): 490-5, 1998.
Volek
JS, et al: Creatine supplementation enhances muscular performance
during high-intensity resistance exercise. J Am Diet Assoc; 97
(7): 765-70, 1997.
(top)
Devil's
Claw (Harpagophytum procumbens)
Bhattacharya A, Bhattacharya SK: Anti-oxidant activity of Harpagophytum
procumbens (Devil's claw).
Br J Phytother; 5 (2): 68-71, 1998.
Blumenthal M, et al (eds.): The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicines. 1st ed: 120-1, ©1998
American Botanical Council.
Castleman M: Devil's claw relieves back pain. Herb Quarterly;
76: 8, 1997.
Chrubasik S, et al: Effectiveness of Harpagophytum extract WS
1531 in the treatment of exacerbation of low back pain: a randomized,
placebo-controlled, double-blind study. Eur J Anaesthesiol; 16
(2): 118-29, 1999.
Devil's claw for arthritis. Health Counselor; 8 (1): 10-11, 1996.
Devil's claw, yucca, aloe vera and jojoba: Healers of the desert.
Nutrition News; 11 (11): 1-4, 1979. 10.
Foster S, Tyler V: Tyler's Honest Herbal. A Sensible Guide to
the Use of Herbs and Related Remedies. 4th ed: 139-40, ©1999.
Kahler CP, et al: Anti-inflammatory properties of devil's claw
(Harpagophytum procumbens) compared to fluticasone. S African
J Sci; 94 (9): 432-40, 1998.
Lanhers MC, et al: Anti-inflammatory and analgesic effects of
an aqueous extract of Harpagophytum procumbens. Planta Med; 58
(2): 117-23, 1992.
Stannard L: Devil's claw: Therapeutic uses. Positive Health; 36:
27-8, 1999.
Tarleton Anne: Devil's claw for low back pain. HerbalGram; 41:
20-21, 1997.
Wegener T: [Therapy of degenerative diseases of the musculoskeletal
system with South African devil's claw]. Wien Med Wochenschr;
149 (8-10): 254-7, 1999.
Whitehouse LW, et al: Devil's claw (Harpagophytum procumbens):
no evidence for anti-inflammatory activity in the treatment of
arthritic disease. Can Med Assoc J; 129 (3): 249-51, 1983.
(top)
DHA
(Docosahexaenoic acid)
Andreassen
AK, et al: Hypertension prophylaxis with omega-3 fatty acids in
heart transplant recipients. J Am Coll Cardiol; 29 (6): 1324-31,
1997.
Carvajal
O, Angulo O: Effect of n-3 polyunsaturated fatty acids on the
lipidic profile of healthy Mexican volunteers. Salud Publica Mex;
39 (3): 221-4, 1997.
Clark
WF, et al: Omega-3 fatty acid dietary supplementation in systemic
lupus erythematosus. Kidney Int; 36 (4): 653-60, 1989.
Davidson
MH, et al: Effects of docosahexaenoic acid on serum lipoproteins
in patients with combined hyperlipidemia: a randomized, double-blind,
placebo-controlled trial. J Am Coll Nutr; 16 (3): 236-43, 1997.
Edwards
R, et al: Omega-3 polyunsaturated fatty acid levels in the diet
and in red blood cell membranes of depressed patients. J Affect
Disord; 48 (2-3): 149-55, 1998.
Friedberg
CE, et al: Fish oil and glycemic control in diabetes. A meta-analysis.
Diabetes Care; 21 (4): 494-500, 1998.
Hirafuji
M, et al: Effect of docosahexanoic acid on smooth muscle cell
functions. Life Sci; 62 (17-18): 1689-93, 1998.
Horrocks
LA, Yeo YK: Health benefits of docosahexaenoic acid. Pharmacol
Res; 40 (3): 211-25, 1999.
Hula
NM, et al: [Lipid composition and fertility of human ejaculate].
WMJ; 65 (4): 64-70, 1993.
Kimura
S, et al: Ameliorative effects of docosahexaenoic acid on serum
lipid changes in stroke-prone spontaneously hypertensive rats.
Res Commun Mol Pathol Pharmacol; 100 (1): 53-64, 1998.
Kremer
JM, et al: Dietary fish oil and olive oil supplementation in patients
with rheumatoid arthritis. Clincial and immunologic effects. Arthritis
Rheum; 33 (6): 810-20, 1990.
Kremer
JM: n-3 fatty acid supplements in rheumatoid arthritis. Am J Clin
Nutr; 71 (1 suppl): 349s-51s, 2000.
Lau CS, et al: Effects of fish oil supplementation on non-steroidal
anti-inflammatory drug requirement in patients with mild rheumatoid
arthritis--a double-blind placebo controlled study. Br J Rheumatol;
32 (11): 982-9, 1993.
Martinez
M, et al: [Treatment of generalized peroxisomal disorders with
docosahexaenoic acid ethyl ether]. Rev Neurol; 28 (suppl 1): s59-64,
1999.
Martinez
M, et al: Therapeutic effects of docosahexaenoic acid ethyl ester
in patients with genrealized peroxisomal disorders. Am J Clin
Nutr; 71 (1 suppl): 376s-85s, 2000.
Martinez
M, Vazquez E: MRI evidence that docosahexaenoic acid ethyl ester
improves mycelination in generalized peroxisomal disorders. Neurology;
51 (1): 26-32, 1998.
McLennan
P, et al: The cardiovascular protective role of docosahexaenoic
acid. Eur J Pharmacol; 300 (1-2): 83-9, 1996.
Prisco
D, et al: Effect of medium-type supplementation with a moderate
dose of n-3 polyunsaturated fatty acids on blood pressure in mild
hypertensive patients. Thromb Res; 91 (3): 105-12, 1998.
Radack
K, et al: The effects of low doses of n-3 fatty acids supplementation
on blood pressure in hypertensive subjects. A randomized controlled
trial. Arch Intern Med; 151 (6): 1173-80, 1991.
Rivellese
AA, et al: Long-term effects of fish oil on insulin resistance
and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Diabetes Care; 19 (11): 1207-13, 1996.
Robinson
DR, et al: Suppression of autoimmune disease by dietary n-3 fatty
acids. J Lipid Res; 34 (8): 1435-44, 1993.
Simopoulos
AP: Omega-3 fatty acids in health and disease and in growth and
development. Am J Clin Nutr; 54 (3): 438-63, 1991.
Sovik
O, et al: Generalized peroxisomal disorder in male twins: fatty
acid composition of serum lipids and response to n-3 fatty acids.
J Inherit Metab Dis; 21 (6): 662-70, 1998.
Toft
I, et al: Effects of n-3 polyunsaturated fatty acids on glucose
homeostasis and blood pressure in essential hypertension. A randomized,
controlled trial. Ann Intern Med; 123 (12): 911-8, 1995.
van
der Tempel H, et al: Effects of fish oil supplementation in rheumatoid
arthritis. Ann Rheum Dis; 49 (2): 76-80, 1990.
Ziboh
VA, et al: Effects of dietary supplementation of fish oil on neutrophil
and epidermal fatty acids. Modulation of clinical course of psoriatic
subjects. Arch Dermatol; 122 (11): 1277-82, 1986.
(top)
Elderberry (Sambucus
nigra)
Blumenthal
M, et al (eds.): The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicines. 1st ed: 124, ©1998
American Botanical Council.
Culpeper
N: The Complete Herbal and English Physician Enlarged, 1653.
Gray
AM, et al: The traditional plant treatment, Sambucus nigra (elder),
exhibits insulin-like and insulin-releasing actions in vitro.
J Nutr; 130 (1): 15-20, 2000.
Grieve
M: Elder. A Modern Herbal, 1931.
Kaack
K, Austed T: Interaction of vitamin C and flavonoids in elderberry
(Sambucus nigra L.) during juice processing. Plant Foods Hum Nutr;
52 (3): 187-98, 1998.
Zakay-Rones
Z, et al: Inhibition of several strains of influenza virus in
vitro and reduction of symptoms by an elderberry extract (Sambucus
nigra L.) during an outbreak of influenza B Panama. J Altern Complement
Med; 1 (4): 361-9, 1995.
(top)
EPA
(Eicosapentaenoic acid)
Astorga
G, et al: [Activated rheumatoid arthritis: effect of dietary supplementation
with omega-3 oils. A controlled double-blind trial]. Rev Med Chil;
119 (3): 267-72, 1991.
Belluzzi
A, et al: Effects of new fish oil derivative on fatty acid phospholipid-membrane
pattern in a group of Crohn's disease patients. Dig Dis Sci; 39
(12): 2589-94, 1994.
Bohn
KA, et al: [Effect on the lipid profile of diet supplemented with
fish oil concentrate]. Tidsskr Nor Laegeforen; 110 (13): 1693-6,
1990.
Carvajal
O, Angulo O: Effect of n-3 polyunsaturated fatty acids on the
lipidic profile of healthy Mexican volunteers. Salud Publica Mex;
39 (3): 221-4, 1997.
Clark
WF, et al: Omega-3 fatty acid supplementation in systemic lupus
erythematosus. Kidney Int; 36 (4): 653-60, 1989.
Danno
K, Sugie N: Combination therapy with low-dose etretinate and eicosapentaenoic
acid for psoriasis vulgaris. J Dermatol; 25 (11): 703-5, 1998.
Friedberg
CE, et al: Fish oil and glycemic control in diabetes. A meta-analysis.
Diabetes Care; 21 (4): 494-500, 1998.
Hillier
K, et al: Incorporation of fatty acids from fish oil and olive
oil into colonic mucosal lipids and effects upon eicosanoid synthesis
in inflammatory bowel disease. Gut; 32 (10): 1151-5, 1991.
Kragballe
K, Fogh K: A low-fat diet supplemented with dietary fish oil (Max-EPA)
results in improvement of psoriasis and in formation of leukotriene
B5. Acta Derm Venereol; 69 (1): 23-8, 1989.
Kremer
JM, et al: Dietary fish oil and olive oil supplementation in patients
with rheumatoid arthritis. Clinical and immunologic effects. Arthritis
Rheum; 33 (6): 810-20, 1990.
Kremer
JM, et al: Fish-oil fatty acid supplementation in active rheumatoid
arthritis. A double-blinded, controlled, crossover study. Ann
Intern Med; 106 (4): 497-503, 1987.
Kremer
JM: n-3 fatty acid supplements in rheumatoid arthritis. Am J Clin
Nutr; 71 (1 Suppl): 349s-51s, 2000.
Lassus
A, et al: Effects of dietary supplementation with polyunsaturated
ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic
arthritis. J Int Med Res; 18 (1): 68-73, 1990.
Lau
CS, et al: Effects of fish oil supplementation on non-stereoidal
anti-inflammatory drug requirement in patients with mild rheumatoid
arthritis-- a double-blind placebo controlled study. Br J Rheumatol;
32 (11): 982-9, 1993.
Nozaki
S, et al: Effects of purified eicosapentaenoic acid ethyl ester
on plasma lipoproteins in primary hypercholesterolemia. Int J
Vitam Nutr Res; 62 (3): 256-60, 1992.
O'Morain
CA: Does nutritional therapy in inflammatory bowel disease have
a primary or an adjunctive role? Scand J Gastroenterol (Suppl);
172: 29-34, 1990.
O'Morain
CA: Nutritional therapy in ambulatory patients. Dig Dis Sci; 32
(12 Suppl): 95s-99s, 1987.
Passfall
J, et al: Different effects of eicosapentaenoic acid and olive
oil on blood pressure, intracellular free platelet calcium, and
plasma lipids in patients with essential hypertension. Clin Investig;
71 (8): 628-33, 1993.
Prickett
JD, et al: A diet enriched with eicosapentaenoic acid suppresses
autoimmune nephritis in female (NZB x NZW) F1 mice. Trans Assoc
Am Physicians; 95: 145-54, 1982.
Prisco
D, et al: Effect of medium-term supplementation with a moderate
dose of n-3 polyunsaturated fatty acids on blood pressure in mild
hypertensive patients. Thromb Res; 91 (3): 105-12, 1998.
Radack
K, et al: The effects of low doses of n-3 fatty acid supplementation
on blood pressure in hypertensive subjects. A randomized controlled
trial. Arch Intern Med; 151 (6): 1173-80, 1991.
Rivellese
AA, et al: Long-term effects of fish oil on insulin resistance
and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Diabetes Care; 19 (11): 1207-13, 1996.
Steiner
A, et al: Effect of fish oil on blood pressure and serum lipids
in hypertension and hyperlipidemia. J Hypertens (Suppl); 7 (3):
s73-6, 1989.
Toft
I, et al: Effects of n-3 polyunsaturated fatty acids on glucose
homeostasis and blood pressure in essential hypertension. A randomized,
controlled trial. Ann Intern Med; 123 (12): 911-8, 1995.
van
der Tempel H, et al: Effects of fish oil supplementation in rheumatoid
arthritis. Ann Rheum Dis; 49 (2): 76-80, 1990.
Volker
D, et al: Efficacy of fish oil concentrate in the treatment of
rheumatoid arthritis. J Rheumatol; 27 (10): 2343-6, 2000.
Walton
AJ, et al: Dietary fish oil and the severity of symptoms in patients
with systemic lupus erythematosus. Ann Rheum Dis; 50 (7): 463-6,
1991.
Yosefy
C, et al: The effect of fish oil on hypertension, plasma lipids
and hemostasis in hypertensive, obese, dyslipidemic patients with
and without diabetes mellitus. Prostaglandins Leukot Essent Fatty
Acids; 61 (2): 83-7, 1999.
Ziboh
VA, et al: Effects of dietary supplementation of fish oil on neutrophil
and epidermal fatty acids. Modulation of clinical course of psoriatic
subjects. Arch Dermatol; 122 (11): 1277-82, 1986.
(top)
Feverfew (Tanacetum
parthenium)
Culpeper
N: The Complete Herbal and English Physician Enlarged, 1653.
Hausen
BM: [Occupational contact allergy to feverfew Tanacetum parthenium
(L.) Schultz-Bip.; Asteraceae]. Derm Beruf Umwelt; 29 (1): 18-21,
1981.
Johnson
ES, et al: Efficacy of feverfew as prophylactic treatment of migraine.
British Med J; 291: 569-73, 1985.
Kowalchik
C, Hylton WH, eds: Rodales Illustrated Encyclopedia of Herbs;
p192-3, ©1987 Rodale Press, Inc.
Loesche
W, et al: Effects of an extract of feverfew (Tanacetum parthenium)
on arachidonic acid metabolism in human blood platelets. Biomed
Biochim Acta; 47 (10-11): s241-3, 1988.
Makheja
AN, Bailey JM: A platelet phospholipase inhibitor from the medicinal
herb feverfew (Tanacetum parthenium). Prostaglandins Leukot Med;
8 (6): 653-60, 1982.
Murphy
JJ, et al: Randomised double-blind placebo controlled trial of
feverfew in migraine prevention. The Lancet; 2 (8604): 189-92,
1988.
Palevitch
D, Earon G, Carasso R: Feverfew (Tanacetum parthenium) as a prophylactic
treatment for migraine: A double-blind placebo-controlled study.
Phytotherapy Res; 11: 508-11, 1997.
PDR®
for Herbal Medicines; 1171-3, ©1998, Medical Economics Co.
Prusinski
A, et al: [Feverfew as a prophylactic treatment of migraine].
Neurol Neurochir Pol; 33 (Suppl 5): 89-95, 1999.
(top)
Flaxseed
Oil
Allman
MA, Pena MM, Pang D: Supplementation with flaxseed oil versus
sunflowerseed oil in healthy young men consuming a low fat diet:
effects on platelet composition and function. Eur J Clin Nutr;
49 (3): 169-78, 1995.
Bourgnoux
P, Koscielny S, et al: Alpha-linolenic acid content of adipose
breast tissue: a host determinant of the risk of early metastasis
in breast cancer. Br J Cancer; 70 (2): 330-34, 1994.
Chan
JK, Bruce VM, McDonald BE: Dietary alpha-linolenic acid is as
effective as oleic acid in lowering blood cholesterol in normolipidemic
men. Am J Clin Nutrition; 53 (5): 1230-4, 1991.
Cunnane
SC, Ganguli S, et al: High alpha-linolenic acid flaxseed (Linum
usitatissimum): some nutritional properties in humans. Br J Nutrition;
69 (2): 443-53, 1993.
Fritsche
KL, Johnston PV: Effect of dietary alpha-linolenic acid on growth,
metastasis, fatty acid profile and prostaglandin production of
two murine mammary adenocarcinomas. J Nutr; 120 (12): 1601-9,
1990.
Galland
L: Increased requirements for essential fatty acids in atopic
individuals: a review with clinical descriptions. J Am Coll Nutr;
5 (2): 213-28, 1986.
Grignani
G, Zucchella M, et al: [Levels of different metabolites of arachidonic
acid in synovial fluid of patients with arthrosis or rheumatoid
arthritis]. Minerva Med; 87(3): 75-79, 1996.
Kremer
JM, Jubiz W, et al: Fish oil fatty acid supplementation in active
rheumatoid arthritis. A double-blind, controlled, crossover study.
Ann Internal Medicine; 106 (4): 497-503, 1987.
Liwiecki
S, Burton JL, Elles K, Horrobin DF: Levels of essential and other
fatty acids in plasma and red cell phospholipids from normal controls
and patients with atopic eczema. Acta Derm Venereol; 71 (3): 224-8,
1991.
Reuter
W, Voigt H, et al: [Long-term oil therapy in elderly patients
with peripheral arterial occlusive disease]. ZFA; 40 (3): 171-5,
1985.
Shapiro
JA, Koepsell TD, et al: Diet and rheumatoid arthritis in women:
a possible protective effect for fish consumption. Epidemiology;
7 (3): 256-63, 1996.
Simopoulos
AP: Essential fatty acids in health and chronic disease. Am J
Clin Nutr; 70 (3 suppl): 560s-569s, 1999.
Singer
P, Jaeger W, et al: Effects of dietary oleic, linoleic and alpha-linolenic
acids on blood pressure, serum lipids, lipoproteins and the formation
of eicosanoid precursors in patients with mild essential hypertension.
J Hum Hypertension; 4 (3): 227-33, 1990.
Thompson
LU, Rickard SE, et al: Flaxseed and its lignan and oil components
reduce mammary tumor growth at a late stage of carcinogenesis.
Carcinogenesis; 17 (6): 1373-6, 1996.
Valquist
C, Berne B, et al: The fatty-acid spectrum in plasma and adipose
tissue in patients with psoriasis. Arch Dermatol Res; 278 (2):
114-9, 1985.
(top)
Folic Acid (Folate)
Anderson
JH, Kerr DJ, Setanoians A, Cooke TG, McArdle CS: A pharmocokinetic
comparison of intravenous versus intra-arterial folinic acid.
British J Cancer; 65 (1): 133-5, 1992.
Barone
C, Astone A, et al: High-dose folinic acid (HDFA) combined with
5-fluorouracil (5-FU) in first line chemotherapy of advanced large
bowel cancer. Eur J Cancer Clin Oncol; 23 (9): 1303-6, 1987.
Benito E, Stiggelbout A, et al: Nutritional factors in colorectal
cancer: a case-control study in Majorca. Int J Cancer; 49 (2):
161-7, 1991.
Bonstrup
A, Hages M, Prinz-Langenohl R, Pietrzik K: Effects of folic acid
and combinations of folic acid and vitamin B-12 on plasma homocysteine
concentrations in healthy, young women. American Journal of Clinical
Nutrition; 69 (5): 1104-10, 1998.
Brattstrom
L, Lindgren A, et al: Hyperhomocysteinaemia in stroke: prevalence
cause and relationships to type of stroke and stroke risk factors.
Eur J Clin Invest; 22 (3): 214-21, 1992.
Clarke
R, Smith AD, et al: Folate, vitamin B-12, and serum total homocysteine
levels in confirmed Alzheimer's disease. Arch Neurol; 55 (11):
1449-55, 1998.
Di
Costanzo F, Bartolucci R, Padialino D, Brugia M, Buzzi F: High-dose
folinic acid and 5-fluorouracil in advanced colorectal cancer.
Cancer Invest; 6 (2): 133-8, 1988.
Erlichman
C, Fine S, Wong A, Elhakim T: A randomized trial of fluorouracil
and folinic acid in patients with metastatic colorectal carcinoma.
J Clin Oncology; 6 (3): 469-75, 1988.
Freudenheim
JL, Graham S, et al: Folate intake and carcinogenesis of the colon
and rectum. Int J Epidemiology; 20 (2): 368-74, 1991.
Israelsson
B, Brattstrom LE, Hultberg BL: Homocysteine and myocardial infarction.
Atherosclerosis; 71 (2-3): 227-33, 1988.
James
SJ, Pogribna M, et al: Abnormal folate metabolism and mutation
in the methylenetetrahydrofolate reductase gene may be maternal
risk factors for Down syndrome. American J Clin Nutrition; 70
(4): 495-501, 1999.
Murray
M: Encyclopedia of Nutritional Supplements: The Essential Guide
for Improving Your Health Naturally: 119-126, 1996.
Potischman
N, Brinton LA, et al: A case-control study of serum folate levels
and invasive cervical cancer. Cancer Res; 51 (18): 4785-9, 1991.
Potischman
N: Nutritional epidemiology of cervical neoplasia. J Nutrition;
123 (2 suppl): 424-9, 1993.
Recommendations
for the use of folic acid to reduce the number of spina bifida
cases and other neural tube defects. JAMA; 269 (10): 1233-1238,
1993.
Selhub
J, Jaques PF, et al: Relationship between plasma homocysteine,
vitamin status, and extracranial carotid artery stenosis in the
Framingham Study population. J Nutrition; 126 (4 suppl): 1258s-65s,
1996.
Susser
E, Brown AS, Klonowski E, Allen RH, Lindenbaum J: Schizophrenia
and impaired homocysteine metabolism: a possible association.
Biol Psychiatry; 44 (2): 141-3, 1998.
Whincup
PH, Refsum H, et al: Serum total homocysteine and coronary heart
disease: prospective study in middle aged men. Heart; 82 (4):
448-54, 1999.
Wong
WY, Eskes TK, et al: Nonsyndromic orofacial clefts: association
with maternal homocysteinemia. Teratology; 60 (5): 253-2547, 1999.
Zhang
S, Hunter DJ, et al: A prospective study of folate intake and
the risk of breast cancer. JAMA; 281 (17): 1632-7, 1999.
(top)
Fo-Ti (Polygonum multiflorum)
Chen
Y, et al: 2,2-Diphenyl-l-picrylhydrazyl radical-scavenging active
components from Polygonum multiflorum thunb. J Agric Food Chem;
47 (6): 2226-8, 1999.
Foster
S, Tyler V: Tyler's Honest Herbal. A Sensible Guide to the Use
of Herbs and Related Remedies. 4th ed: 163-5, ©1999.
Hong
CY, et al: Astragalus membranaceus and Polygonum multiflorum protect
rat heart mitochondria against lipid peroxidation. Am J Chin Med;
22 (1): 63-70, 1994.
Hsu
HY, et al: Oriental Materia Medica. A Concise Guide: 547-8, Keats
Publishing, ©1986.
Tierra
M: The Way of Herbs; 274-5, 1990.
Yim
TK, et al: Myocardial protection aginst ischaemia-reperfusion
injury by a Polygonum multiflorum extract supplemented 'Dang-Gui
decoction for enriching blood', a compound formulation, ex vivo.
Phytother Res; 14 (3): 195-9, 2000.
Yim
TK, et al: Myocardial protective effect of an anthraquinone-containing
extract of Polygonum multiflorum ex vivo. Planta Med; 64 (7):
607-11, 1998.
(top)
Ginger
(Zingiber officinale)
Ahmed
RS, et al: Influence of dietary ginger (Zingiber officinale Rosc)
on oxidative stress induced by malathion in rats. Food Chem Toxicol;
38 (5): 443-50, 2000.
Aikins
Murphy P: Alternative therapies for nausea and vomiting of pregnancy.
Obstet Gynecol; 91 (1): 149-55, 1998.
Arfeen
Z, et al: A double-blind randomized controlled trial of ginger
for the prevention of postoperative nausea and vomiting. Anaesth
Intensive Care; 23 (4): 449-52, 1995.
Bhandari
U, et al: The protective effect of ethanolic ginger (Zingiber
officinale) extract in cholesterol fed rabbits. J Ethnopharmacol;
61 (2): 167-71, 1998.
Blumenthal
M, et al (eds.): The Complete German Commission E Monographs:
Therapeutic Guide to Herbal Medicines. 1st ed: 135-36, ©1998
American Botanical Council.
Bone
ME, et al: Ginger root--a new antiemetic. The effect of ginger
root on postoperative nausea and vomiting after major gynaecological
surgery. Anaesthesia; 45 (8): 669-71, 1990.
Ernst
E, Pittler H: Efficacy of ginger for nausea and vomiting: a systematic
revue of randomized clinical trials. Br J Anaesth; 84 (3): 367-71,
2000.
Fuhrman
B, et al: Ginger extract consumption reduces plasma cholesterol,
inhibits LDL oxidation and attenuates development of atherosclerosis
in atherosclerotic, apolipoprotein E-deficient mice. J Nutr; 130
(5): 1124-31, 2000.
Grontved
A, et al: Ginger root against seasickness. A controlled trial
on the open sea. Acta Otolaryngol; 105 (1-2): 45-9, 1988.
Guh
JH, et al: Antiplatelet effect of gingerol isolated from Zingiber
officanale. J Pharm Pharmacol; 47 (4): 329-32, 1995.
Hsu
HY, et al: Oriental Materia Medica. A Concise Guide; 64-5, ©1986.
Jewell
D, Young G: Interventions for nausea and vomiting in early pregnancy.
Cochrane Database Syst Rev 2000; (2): CD000145, 2000.
Murray
MT: The Healing Power of Herbs. The Enlightened Persons Guide
to the Wonders of Medicinal Plants. Rev & expanded 2nd ed:
132-40, ©1995.
Phillips
S, et al: Zingiber officinale (ginger)--an antiemetic for day
case surgery. Anaesthesia; 48 (8): 715-7, 1993.
Srivastava
KC: Aqueous extracts of onion, garlic and ginger inhibit platelet
aggregation and alter arachidonic acid metabolism. Biomed Biochim
Acta; 43 (8-9): s335-46, 1984.
Srivastava
KC: Effects of aqueous extracts of onion, garlic and ginger on
platelet aggregation and metabolism of arachidonic acid in the
blood vascular system: in vitro study. Prostaglandins Leukot Med;
13 (2): 227-35, 1984.
Verma
SK, et al: Effect of ginger on platelet aggregation in man. Indian
J Med Res,; 98: 240-2, 1993.
Visalyaputra
S, et al: The efficacy of ginger root in the prevention of postoperative
nausea and vomiting after outpatient gynaecological laparoscopy.
Anaesthesia; 53 (5): 506-10, 1998.
Yamahara
J, et al: [Stomachic principles in ginger. II. Pungent and anti-ulcer
effects of low polar constituents isolated from ginger, the dried
rhizoma of Zingiber officinale Roscoe cultivated in Taiwan. The
absolute stereostructure of a new diaryheptanoid]. Yakugaku Zasshi;
112 (9): 645-55, 1992.
Yoshikawa
M, et al: 6-Gingesulfonic acid, a new anti-ulcer principle, and
gingerglycolipids A, B, and C, three new monoacyldigalactosylglycerols,
from zingiberis rhizoma originating in Taiwan. Chem Pharm Bull;
40 (8): 2239-41, 1992
(top).
Ginkgo
biloba (Ginkgo biloba)
Bauer
U: 6-month double-blind randomised clinical trial of Ginkgo biloba
extract versus placebo in two parallel groups in patients suffering
from peripheral arterial insufficiency. Arzneimittelforschung;